Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

IMPORTANCE: To our knowledge, this is the first randomized trial in sex cord-stromal tumors, and it establishes weekly paclitaxel as standard-of-care therapy after platinum-based therapy in this setting. OBJECTIVE: To determine the efficacy of weekly paclitaxel with or without bevacizumab as treatme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Ray-Coquard, Isabelle, Harter, Philipp, Lorusso, Domenica, Dalban, Cécile, Vergote, Ignace, Fujiwara, Keiichi, Gladieff, Laurence, Lück, Hans-Joachim, Floquet, Anne, Chevalier-Place, Annick, Schnelzer, Andreas, Pignata, Sandro, Selle, Frédéric, Sehouli, Jalid, Brocard, Fabien, Mangili, Giorgia, Pautier, Patricia, De Giorgi, Ugo, Provansal, Magali, Heudel, Pierre-Etienne
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545353/
https://ncbi.nlm.nih.gov/pubmed/33030515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.4574
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars